{"id":5665,"date":"2023-12-28T11:35:51","date_gmt":"2023-12-28T16:35:51","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=5665"},"modified":"2026-04-13T13:07:49","modified_gmt":"2026-04-13T17:07:49","slug":"revolutionizing-drug-level-detection-neomer-aptamers","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/fr\/revolutionizing-drug-level-detection-neomer-aptamers\/","title":{"rendered":"Revolutionizing Drug Level Detection: Neomer Aptamers"},"content":{"rendered":"<ul>\n<li>La m\u00e9thode de s\u00e9lection d'aptam\u00e8res Neomer de NeoVentures remplace le processus traditionnel SELEX, offrant un environnement clos et reproductible pour le d\u00e9veloppement d'aptam\u00e8res, garantissant ainsi la coh\u00e9rence dans la d\u00e9tection des niveaux de m\u00e9dicaments.<\/li>\n<li>L'inclusion d'une \u00e9tape d'immunotol\u00e9rance in silico am\u00e9liore la sp\u00e9cificit\u00e9 et la s\u00e9lectivit\u00e9 des aptam\u00e8res Neomer, les rendant plus pr\u00e9cis dans la d\u00e9tection des m\u00e9dicaments, en particulier \u00e0 faible concentration.<\/li>\n<li>Les aptam\u00e8res Neomer surpassent les anticorps en termes de taille, de stabilit\u00e9 et de propri\u00e9t\u00e9s de liaison, offrant ainsi une solution polyvalente et avanc\u00e9e pour la d\u00e9tection pr\u00e9cise du niveau de m\u00e9dicaments en diagnostics mol\u00e9culaires.<\/li>\n<\/ul>\n<p>Dans le domaine des diagnostics mol\u00e9culaires et des th\u00e9rapies cibl\u00e9es, la d\u00e9tection pr\u00e9cise des niveaux de m\u00e9dicaments, en particulier \u00e0 faible concentration, est cruciale pour un traitement efficace des patients. Les m\u00e9thodes traditionnelles reposent souvent sur les anticorps, mais de nouvelles technologies remettent en question le statu quo. NeoVentures, un pionnier dans le domaine, est \u00e0 l'avant-garde de cette r\u00e9volution avec leur m\u00e9thode brevet\u00e9e de s\u00e9lection d'aptam\u00e8res Neomer. Cette approche innovante remplace non seulement la m\u00e9thode traditionnelle SELEX, mais transforme \u00e9galement la s\u00e9lection d'aptam\u00e8res d'un art en une science reproductible.<\/p>\n<h3>L'Avantage Neomer :<\/h3>\n<ol>\n<li><em>Reproductibilit\u00e9 :<\/em> Le m\u00e9thode de s\u00e9lection Neomer de NeoVentures marque un changement de paradigme par rapport \u00e0 la nature impr\u00e9visible des processus de s\u00e9lection traditionnels des aptam\u00e8res. En d\u00e9pla\u00e7ant la s\u00e9lection d'un art \u00e0 une science dans un espace clos, Neomer garantit une reproductibilit\u00e9 qui \u00e9tait autrefois difficile \u00e0 obtenir dans le domaine. Cette constance est essentielle pour des tests de diagnostic fiables et normalis\u00e9s.<\/li>\n<li><em>In-Silico Immune Tolerance:<\/em> L'un des \u00e9l\u00e9ments cl\u00e9s qui distingue Neomer est son int\u00e9gration d'une \u00e9tape d'immuno-tol\u00e9rance in-silico. Cette \u00e9tape ajuste finement le processus de s\u00e9lection des aptam\u00e8res, garantissant que les aptam\u00e8res r\u00e9sultants pr\u00e9sentent une grande sp\u00e9cificit\u00e9 et s\u00e9lectivit\u00e9 pour leur cible. Ce niveau de pr\u00e9cision est sans pr\u00e9c\u00e9dent et am\u00e9liore les performances globales des aptam\u00e8res dans la d\u00e9tection des niveaux de m\u00e9dicaments.<\/li>\n<li><em>Sp\u00e9cificit\u00e9 et S\u00e9lectivit\u00e9 :<\/em> Les m\u00e9thodes traditionnelles de s\u00e9lection des aptam\u00e8res peuvent produire des mol\u00e9cules ayant une grande affinit\u00e9 mais sans sp\u00e9cificit\u00e9, ce qui entra\u00eene des probl\u00e8mes de r\u00e9activit\u00e9 crois\u00e9e. L'\u00e9tape d'immunit\u00e9 in silico de Neomer affine les aptam\u00e8res, am\u00e9liorant leur sp\u00e9cificit\u00e9 et leur s\u00e9lectivit\u00e9. Cette pr\u00e9cision est particuli\u00e8rement avantageuse pour d\u00e9tecter des m\u00e9dicaments pr\u00e9sents en faibles concentrations, o\u00f9 l'exactitude est primordiale.<\/li>\n<li><em>Haute Affinit\u00e9 :<\/em> Tout en se concentrant sur la sp\u00e9cificit\u00e9, Neomer ne fait aucun compromis en ce qui concerne l'affinit\u00e9. Les aptam\u00e8res g\u00e9n\u00e9r\u00e9s gr\u00e2ce \u00e0 cette m\u00e9thode conservent leur haute affinit\u00e9 pour la cible, garantissant la sensibilit\u00e9 dans la d\u00e9tection des niveaux de m\u00e9dicaments. Ce double avantage de haute affinit\u00e9 et de sp\u00e9cificit\u00e9 positionne les aptam\u00e8res Neomer comme des outils sup\u00e9rieurs en diagnostics mol\u00e9culaires.<\/li>\n<li><em>Polyvalence :<\/em> Les aptam\u00e8res Neomer offrent une polyvalence dans leurs applications, ce qui les rend adapt\u00e9s \u00e0 une large gamme de sc\u00e9narios de d\u00e9tection de m\u00e9dicaments. Que ce soit pour surveiller les niveaux de m\u00e9dicaments th\u00e9rapeutiques chez les patients ou pour mener des recherches en laboratoire, l'adaptabilit\u00e9 des aptam\u00e8res Neomer contribue \u00e0 leur applicabilit\u00e9 \u00e9tendue.<\/li>\n<li><em>Advancement Beyond Antibodies:<\/em> Par rapport aux anticorps, les aptam\u00e8res Neomer pr\u00e9sentent plusieurs avantages. Ils sont de taille plus petite, plus stables et peuvent \u00eatre synth\u00e9tis\u00e9s plus facilement. De plus, leur capacit\u00e9 \u00e0 se lier avec une sp\u00e9cificit\u00e9 et une affinit\u00e9 \u00e9lev\u00e9es \u00e0 une gamme diversifi\u00e9e de cibles les positionne comme une alternative de pointe aux anticorps traditionnels.<\/li>\n<\/ol>\n<p>Dans la qu\u00eate de la d\u00e9tection pr\u00e9cise et fiable des niveaux de m\u00e9dicaments, les aptam\u00e8res Neomer de NeoVentures brillent comme un phare de l'innovation. La transition de l'art \u00e0 la science dans la s\u00e9lection des aptam\u00e8res, associ\u00e9e \u00e0 l'\u00e9tape de tol\u00e9rance immunitaire in silico, marque un pas en avant significatif. La reproductibilit\u00e9, la sp\u00e9cificit\u00e9 et la haute affinit\u00e9 des aptam\u00e8res Neomer, combin\u00e9es \u00e0 leur polyvalence, en font le choix id\u00e9al pour les applications o\u00f9 la pr\u00e9cision de la d\u00e9tection des niveaux de m\u00e9dicaments est primordiale. \u00c0 mesure que le paysage des diagnostics mol\u00e9culaires \u00e9volue, les aptam\u00e8res Neomer de NeoVentures t\u00e9moignent de la transformation continue du domaine.<\/p>","protected":false},"excerpt":{"rendered":"<p>NeoVentures&#8217; Neomer aptamer selection method replaces the traditional SELEX process, offering a closed and reproducible space for aptamer development, ensuring consistency in drug level detection. The inclusion of an in-silico immune tolerance step enhances Neomer aptamers&#8217; specificity and selectivity, making them more precise in detecting drugs, especially in low concentrations. Neomer aptamers surpass antibodies in&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/fr\/revolutionizing-drug-level-detection-neomer-aptamers\/\" rel=\"bookmark\">Lire la suite &raquo;<span class=\"screen-reader-text\">Revolutionizing Drug Level Detection: Neomer Aptamers<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":2942,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[8,18],"tags":[],"class_list":["post-5665","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aptamers","category-neomers"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Revolutionizing Drug Level Detection: Neomer Aptamers<\/title>\n<meta name=\"description\" content=\"NeoVentures, a pioneer in the field, is at the forefront of this revolution with their patented Neomer aptamer selection method.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/fr\/revolutionizing-drug-level-detection-neomer-aptamers\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revolutionizing Drug Level Detection: Neomer Aptamers\" \/>\n<meta property=\"og:description\" content=\"NeoVentures, a pioneer in the field, is at the forefront of this revolution with their patented Neomer aptamer selection method.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/fr\/revolutionizing-drug-level-detection-neomer-aptamers\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-28T16:35:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T17:07:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Untitled-design-114.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1300\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"Revolutionizing Drug Level Detection: Neomer Aptamers\",\"datePublished\":\"2023-12-28T16:35:51+00:00\",\"dateModified\":\"2026-04-13T17:07:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/\"},\"wordCount\":557,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/Untitled-design-114.png\",\"articleSection\":[\"Aptamers\",\"Neomer\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/\",\"name\":\"Revolutionizing Drug Level Detection: Neomer Aptamers\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/Untitled-design-114.png\",\"datePublished\":\"2023-12-28T16:35:51+00:00\",\"dateModified\":\"2026-04-13T17:07:49+00:00\",\"description\":\"NeoVentures, a pioneer in the field, is at the forefront of this revolution with their patented Neomer aptamer selection method.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/Untitled-design-114.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/Untitled-design-114.png\",\"width\":1300,\"height\":800,\"caption\":\"Microscope and array of test tubes on a laboratory bench.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/revolutionizing-drug-level-detection-neomer-aptamers\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revolutionizing Drug Level Detection: Neomer Aptamers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revolutionizing Drug Level Detection: Neomer Aptamers","description":"NeoVentures, a pioneer in the field, is at the forefront of this revolution with their patented Neomer aptamer selection method.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/fr\/revolutionizing-drug-level-detection-neomer-aptamers\/","og_locale":"fr_FR","og_type":"article","og_title":"Revolutionizing Drug Level Detection: Neomer Aptamers","og_description":"NeoVentures, a pioneer in the field, is at the forefront of this revolution with their patented Neomer aptamer selection method.","og_url":"https:\/\/neoaptamers.com\/fr\/revolutionizing-drug-level-detection-neomer-aptamers\/","og_site_name":"neoaptamers","article_published_time":"2023-12-28T16:35:51+00:00","article_modified_time":"2026-04-13T17:07:49+00:00","og_image":[{"width":1300,"height":800,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Untitled-design-114.png","type":"image\/png"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gregory Penner","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"Revolutionizing Drug Level Detection: Neomer Aptamers","datePublished":"2023-12-28T16:35:51+00:00","dateModified":"2026-04-13T17:07:49+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/"},"wordCount":557,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Untitled-design-114.png","articleSection":["Aptamers","Neomer"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/","url":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/","name":"Revolutionizing Drug Level Detection: Neomer Aptamers","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Untitled-design-114.png","datePublished":"2023-12-28T16:35:51+00:00","dateModified":"2026-04-13T17:07:49+00:00","description":"NeoVentures, a pioneer in the field, is at the forefront of this revolution with their patented Neomer aptamer selection method.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Untitled-design-114.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2022\/08\/Untitled-design-114.png","width":1300,"height":800,"caption":"Microscope and array of test tubes on a laboratory bench."},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/revolutionizing-drug-level-detection-neomer-aptamers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"Revolutionizing Drug Level Detection: Neomer Aptamers"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/comments?post=5665"}],"version-history":[{"count":3,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5665\/revisions"}],"predecessor-version":[{"id":6497,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5665\/revisions\/6497"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media\/2942"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media?parent=5665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/categories?post=5665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/tags?post=5665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}